We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Medical writing in India at a crossroads.
- Authors
Bose, Salil
- Abstract
Pharmaceutical regulatory medical writing for document submissions to Western health regulatory agencies has been undertaken in India for almost 10 years. From humble beginnings in a couple of non-Indian pharmaceutical multinational giants - Novartis and Sanofi-Aventis (as it was) - this activity has now expanded into multiple companies and almost a dozen information technology firms and contract research organisations. The biggest advantage is the cost, although this often comes at a 'price', in terms of document quality. However, medical writing in India may be turning a corner for the good as a result of the rapidly increasing body of experience in the field.
- Subjects
INDIA; MEDICAL writing; GOVERNMENT agencies; PHARMACEUTICAL industry; INTERNATIONAL business enterprises; NOVARTIS AG; SANOFI-Aventis SA
- Publication
Medical Writing, 2013, Vol 22, Issue 2, p94
- ISSN
2047-4806
- Publication type
Article
- DOI
10.1179/2047480613Z.000000000106